Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Nasal polyps
ADR ID BADD_A02970
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.38      Respiratory and mediastinal neoplasms benign (excl mesotheliomas)
16.38.01      Nasal and paranasal sinus neoplasms benign
16.38.01.001      Nasal polyps
22      Respiratory, thoracic and mediastinal disorders
22.04      Upper respiratory tract disorders (excl infections)
22.04.03      Nasal disorders NEC
22.04.03.010      Nasal polyps
Description Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations. [MeSH]
MedDRA Code 10028756
MeSH ID D009298
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Nasal polyp | Nasal polyps | Polyp of nasal cavity | Polyps nasal | Unspecified nasal polyp | Hyperplastic nasal polyp | Choanal polyp | Nasal Polyps | Nasal Polyp | Polyp, Nasal | Polyps, Nasal
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00033Acetylsalicylic acid0.000077%
BADD_D00066Alendronic acid0.000044%
BADD_D00151Apixaban0.000065%
BADD_D00306Budesonide0.000093%
BADD_D00335Calcitonin--
BADD_D00417Cetirizine--
BADD_D00418Cetirizine hydrochloride--
BADD_D00711Dornase alfa--
BADD_D00809Escitalopram--
BADD_D00898Finasteride0.000112%
BADD_D00946Fluticasone furoate--
BADD_D00947Fluticasone propionate--
BADD_D01191Ipratropium--
BADD_D01192Ipratropium bromide--
BADD_D01213Isotretinoin0.000257%
BADD_D01431Methylphenidate--
BADD_D01490Mometasone0.000131%
BADD_D01491Mometasone furoate--
BADD_D01533Naproxen--
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01834Prednisone--
BADD_D01966Ropinirole--
BADD_D02236Tofacitinib0.000772%
The 1th Page    1    Total 1 Pages